Nanobiotix Aktie - 0QAV

Nanobiotix (0QAV) Aktie

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Current Price

6,3825

( - )

Gebot

6,225

Fragen

6,54

Volumen

2.295

0,00 Tagesbereich 0,00

6,3825 52-Wochen-Bereich 6,3825

Marktkapitalisierung

323,682M

Handelsende

6,3825

Handelsbeginn

Letzte Trade

31.46

(O)

Letzter Handelszeitpunkt

13:22:05

Finanzvolumen

VWAP

Durchschnittliches Volumen (3 Mio.)

248.411 €

Ausgegebene Aktien

50.713.979

Dividendenrendite (LTM)

Kurs-Gewinn-Verhältnis

-61,07

Gewinn pro Aktie (EPS)

-0,5

Erlöse (LTM)

32,59M

Nettogewinn (LTM)

-23,96M

Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of ... Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck, liver, prostate, pancreatic, esophageal, rectal, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is based in Paris, France. Mehr anzeigen

Sektor

Branche

Website

www.nanobiotix.com

Hauptsitz

Paris, France

Gegründet

2026

Nanobiotix is listed in the sector of the Londoner Börse with ticker 0QAV. The last closing price for Nanobiotix was 6,38 €. Over the last year, Nanobiotix shares have traded in a share price range of 6,3825 € to 6,3825 €.

Nanobiotix currently has 50.713.979 shares in issue. The market capitalisation of Nanobiotix is 323,68 € million. Nanobiotix has a price to earnings ratio (PE ratio) of -61.07.

Voting Rights and Shares Capital of the Company

Voting Rights and Shares Capital of the Company In accordance with articles L.233-8 II of the French Commercial Code and 223-16 of the General...

Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social

Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social Conformément aux articles L.233-8 II du...

Nanobiotix Provides First Quarter 2026 Operational and Financial Update

Nanobiotix Provides First Quarter 2026 Operational and Financial Update Completed a follow-on offering in May 2026 for aggregate gross proceeds of...

Nanobiotix fait le point sur sa tresorerie et son activite operationnelle pour le premier trimestre 2026

Nanobiotix fait le point sur sa tresorerie et son activite operationnelle pour le premier trimestre 2026 Réalisation d’une augmentation de capital...

Nanobiotix Joins the Euronext Tech Leaders Index

Nanobiotix Joins the Euronext Tech Leaders Index PARIS and CAMBRIDGE, Mass., June 02, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO...

Nanobiotix rejoint l'indice Euronext Tech Leaders

Nanobiotix rejoint l'indice Euronext Tech Leaders PARIS et CAMBRIDGE, Mass., 02 juin 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext : NANO –...

NANOBIOTIX annonce le règlement-livraison de son offre globale

NANOBIOTIX annonce le règlement-livraison de son offre globale PARIS and CAMBRIDGE, Mass., 26 mai 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX...

NANOBIOTIX Announces Closing of Global Offering

NANOBIOTIX Announces Closing of Global Offering PARIS and CAMBRIDGE, Mass., May 26, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –...

NANOBIOTIX Announces Full Exercise of Underwriters’ Over-Allotment Option, Bringing Gross Proceeds of Offering to Approximately $100 Million

NANOBIOTIX Announces Full Exercise of Underwriters’ Over-Allotment Option, Bringing Gross Proceeds of Offering to Approximately $100 Million PARIS...

NANOBIOTIX annonce l’exercice integral de l’option de surallocation, portant le produit de l'offre a 100 millions de dollars

NANOBIOTIX annonce l’exercice integral de l’option de surallocation, portant le produit de l'offre a 100 millions de dollars PARIS et...

Zeitraum †	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	DE
4	0	0	0	0	0	DE
12	0	0	0	0	0	DE
26	6.3825	6.3825	6.3825	11329	6.3825	DE
52	6.3825	6.3825	6.3825	18853	6.3825	DE
156	6.3825	6.3825	6.3825	9771	6.3825	DE
260	6.3825	6.3825	6.3825	7413	6.3825	DE

0QAV - Frequently Asked Questions (FAQ)

What is the current Nanobiotix share price?

The current share price of Nanobiotix is 6,3825 €

How many Nanobiotix shares are in issue?

Nanobiotix has 50.713.979 shares in issue

What is the market cap of Nanobiotix?

The market capitalisation of Nanobiotix is EUR 323,68M

What is the 1 year trading range for Nanobiotix share price?

Nanobiotix has traded in the range of 6,3825 € to 6,3825 € during the past year

What is the PE ratio of Nanobiotix?

The price to earnings ratio of Nanobiotix is -61,07

What is the cash to sales ratio of Nanobiotix?

The cash to sales ratio of Nanobiotix is 47,61

What is the registered address of Nanobiotix?

The registered address for Nanobiotix is 60 rue de Wattignies, Paris, Ile-de-France, 75012

What is the Nanobiotix website address?

The website address for Nanobiotix is www.nanobiotix.com

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Nanobiotix (0QAV)

Nanobiotix (0QAV) Aktie

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Über Nanobiotix

0QAV Neueste Nachrichten

Voting Rights and Shares Capital of the Company

Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social

Nanobiotix Provides First Quarter 2026 Operational and Financial Update

Nanobiotix fait le point sur sa tresorerie et son activite operationnelle pour le premier trimestre 2026

Nanobiotix Joins the Euronext Tech Leaders Index

Nanobiotix rejoint l'indice Euronext Tech Leaders

NANOBIOTIX annonce le règlement-livraison de son offre globale

NANOBIOTIX Announces Closing of Global Offering

NANOBIOTIX Announces Full Exercise of Underwriters’ Over-Allotment Option, Bringing Gross Proceeds of Offering to Approximately $100 Million

NANOBIOTIX annonce l’exercice integral de l’option de surallocation, portant le produit de l'offre a 100 millions de dollars

Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social

Voting Rights and Shares Capital of the Company

Nanobiotix fait le point sur sa tresorerie et son activite operationnelle pour le premier trimestre 2026

Nanobiotix Provides First Quarter 2026 Operational and Financial Update

Nanobiotix rejoint l'indice Euronext Tech Leaders

Nanobiotix Joins the Euronext Tech Leaders Index

NANOBIOTIX Announces Closing of Global Offering

NANOBIOTIX annonce le règlement-livraison de son offre globale

0QAV - Frequently Asked Questions (FAQ)

0QAV Trades

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Registrieren Sie sich GRATIS und erhalten Sie:

Werbung entfernen